https://www.selleckchem.com/pr....oducts/Fasudil-HCl(H
All randomised phase 3 studies of selective internal radiation therapy for advanced hepatocellular carcinoma published to date have reported negative results. However, these studies did not use personalised dosimetry. We aimed to compare the efficacy of a personalised versus standard dosimetry approach of selective internal radiation therapy with yttrium-90-loaded glass microspheres in patients with hepatocellular carcinoma. DOSISPHERE-01 was a randomised, multicentre, open-label phase 2 trial done at four health-care centr
Like
Comment
Share
